Kiwi biotechs aim for US boost

Kiwi biotechs aim for US boost

Date added: Tuesday, 10 January 2012 11:59

It costs more than $200 a minute to present your business to 1300 specialist investors at Biotech Showcase in San Francisco this week, but the 25-minute slot on stage is not the main attraction for five Kiwi businesses attending.

''If you're looking to roll out your business in the healthcare space, these are the right people to meet,'' says Pacific Edge CEO David Darling.

Two other New Zealand companies - Innate Immunotherapeutics and Polybatics - are making presentations, while CoDa Therapeutics and Mesynthes, the latter backed by Wellington venture capital firm Movac and the NZ Venture Investment Fund, are also attendees.

Read more from Stuff.co.nz

< Prev		Next >